TY - JOUR
T1 - Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome
AU - Barbara, Giovanni
AU - Stanghellini, Vincenzo
AU - De Giorgio, Roberto
AU - Cremon, Cesare
AU - Cottrell, Graeme
AU - Santini, Donatella
AU - Pasquinelli, Gianandrea
AU - Morselli-Labate, Antonio
AU - Grady, Eileen
AU - Bunnett, Nigel
AU - Collins, Stephen
AU - Corinaldesi, Roberto
PY - 2004
Y1 - 2004
N2 - The mechanisms underlying abdominal pain perception in irritable bowel syndrome (IBS) are poorly understood. Intestinal mast cell infiltration may perturb nerve function leading to symptom perception. We assessed colonic mast cell infiltration, mediator release, and spatial interactions with mucosal innervation and their correlation with abdominal pain in IBS patients.
IBS patients were diagnosed according to Rome II criteria and abdominal pain quantified according to a validated questionnaire. Colonic mucosal mast cells were identified immunohistochemically and quantified with a computer-assisted counting method. Mast cell tryptase and histamine release were analyzed immunoenzymatically. Intestinal nerve to mast cell distance was assessed with electron microscopy.
Thirty-four out of 44 IBS patients (77 ) showed an increased area of mucosa occupied by mast cells as compared with controls (9.2 +/- 2.5 vs. 3.3 +/- 0.8 , respectively; P <0.001). There was a 150 increase in the number of degranulating mast cells (4.76 +/- 3.18/field vs. 2.42 +/- 2.26/field, respectively; P = 0.026). Mucosal content of tryptase was increased in IBS and mast cells spontaneously released more tryptase (3.22 +/- 3.48 pmol/min/mg vs. 0.87 +/- 0.65 pmol/min/mg, respectively; P = 0.015) and histamine (339.7 +/- 59.0 ng/g vs. 169.3 +/- 130.6 ng/g, respectively; P = 0.015). Mast cells located within 5 um of nerve fibers were 7.14 +/- 3.87/field vs. 2.27 +/- 1.63/field in IBS vs. controls (P <0.001). Only mast cells in close proximity to nerves were significantly correlated with severity and frequency of abdominal pain/discomfort (P <0.001 and P = 0.003, respectively).
Colonic mast cell infiltration and mediator release in proximity to mucosal innervation may contribute to abdominal pain perception in IBS patients.
AB - The mechanisms underlying abdominal pain perception in irritable bowel syndrome (IBS) are poorly understood. Intestinal mast cell infiltration may perturb nerve function leading to symptom perception. We assessed colonic mast cell infiltration, mediator release, and spatial interactions with mucosal innervation and their correlation with abdominal pain in IBS patients.
IBS patients were diagnosed according to Rome II criteria and abdominal pain quantified according to a validated questionnaire. Colonic mucosal mast cells were identified immunohistochemically and quantified with a computer-assisted counting method. Mast cell tryptase and histamine release were analyzed immunoenzymatically. Intestinal nerve to mast cell distance was assessed with electron microscopy.
Thirty-four out of 44 IBS patients (77 ) showed an increased area of mucosa occupied by mast cells as compared with controls (9.2 +/- 2.5 vs. 3.3 +/- 0.8 , respectively; P <0.001). There was a 150 increase in the number of degranulating mast cells (4.76 +/- 3.18/field vs. 2.42 +/- 2.26/field, respectively; P = 0.026). Mucosal content of tryptase was increased in IBS and mast cells spontaneously released more tryptase (3.22 +/- 3.48 pmol/min/mg vs. 0.87 +/- 0.65 pmol/min/mg, respectively; P = 0.015) and histamine (339.7 +/- 59.0 ng/g vs. 169.3 +/- 130.6 ng/g, respectively; P = 0.015). Mast cells located within 5 um of nerve fibers were 7.14 +/- 3.87/field vs. 2.27 +/- 1.63/field in IBS vs. controls (P <0.001). Only mast cells in close proximity to nerves were significantly correlated with severity and frequency of abdominal pain/discomfort (P <0.001 and P = 0.003, respectively).
Colonic mast cell infiltration and mediator release in proximity to mucosal innervation may contribute to abdominal pain perception in IBS patients.
U2 - 10.1053/j.gastro.2003.11.055
DO - 10.1053/j.gastro.2003.11.055
M3 - Article
SN - 0016-5085
VL - 126
SP - 693
EP - 702
JO - Gastroenterology
JF - Gastroenterology
IS - 3
ER -